Literature DB >> 3893310

Obesity and the risk of cardiovascular disease.

P Björntorp.   

Abstract

The original notion that obesity is associated with disease and premature death was obtained from insurance statistics, which have been rightfully criticized for representing selected populations. In prospective, epidemiological studies a long period of observation on a large number of subjects is needed before obesity can be recognized as a risk factor for cardiovascular disease in spite of the fact that well-known risk factors for such disease are prevalent in obesity populations. This apparent paradox may be explained by the possibility that the risk of getting cardiovascular disease is present mainly in a subgroup of the total obese population. Such a subgroup might be characterized by the distribution of adipose tissue. Indeed abdominal obesity has been demonstrated consistently to be strongly associated with risk factors for cardiovascular disease in cross-sectional investigations of older and more recent dates. Several prospective longitudinal, epidemiological studies in both men and women have shown that abdominal obesity is associated with an increased risk of getting ischemic heart disease, stroke and death, independent of the total degree of obesity. The findings from these recent prospective studies, supported by previous unanimous cross-sectional studies as well as the fact that reasonable potential explanations for the statistical associations have been suggested, now seem to allow the conclusion that abdominal obesity should even be treated when present to a very limited extent. In such subjects, exclusion of conditions complicating obesity should also be performed vigorously. Abdominal obesity can be diagnosed by very simple means: measuring the abdominal circumference in relation to hip circumference.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 3893310

Source DB:  PubMed          Journal:  Ann Clin Res        ISSN: 0003-4762


  10 in total

1.  Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  B A Reeder; A Angel; M Ledoux; S W Rabkin; T K Young; L E Sweet
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

2.  Using nature to understand nurture.

Authors:  T B VanItallie; A J Stunkard
Journal:  Am J Public Health       Date:  1990-06       Impact factor: 9.308

3.  Relationships of generalized and regional adiposity to insulin sensitivity in men.

Authors:  N Abate; A Garg; R M Peshock; J Stray-Gundersen; S M Grundy
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 4.  The importance of physical fitness for the reduction of coronary artery disease risk factors.

Authors:  D R Young; M A Steinhardt
Journal:  Sports Med       Date:  1995-05       Impact factor: 11.136

5.  Prevalence of non-insulin-dependent diabetes mellitus and impaired glucose tolerance in two Algonquin communities in Quebec.

Authors:  H F Delisle; J M Ekoé
Journal:  CMAJ       Date:  1993-01-01       Impact factor: 8.262

Review 6.  Genetic aspects of susceptibility to obesity and related dyslipidemias.

Authors:  J P Després; S Moorjani; P J Lupien; A Tremblay; A Nadeau; C Bouchard
Journal:  Mol Cell Biochem       Date:  1992-08-18       Impact factor: 3.396

7.  Body fat distribution, blood pressure and blood glucose in Egyptian obese women undergoing a weight control program.

Authors:  S M el-Shebini; S T Tapozada; L M Hanna
Journal:  Z Ernahrungswiss       Date:  1993-06

Review 8.  Clinical significance of visceral adiposity assessed by computed tomography: A Japanese perspective.

Authors:  Miwa Ryo; Ken Kishida; Tadashi Nakamura; Tohru Yoshizumi; Tohru Funahashi; Iichiro Shimomura
Journal:  World J Radiol       Date:  2014-07-28

Review 9.  Rimonabant for overweight or obesity.

Authors:  C Curioni; C André
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 10.  Metabolic complications of obesity.

Authors:  S M Grundy
Journal:  Endocrine       Date:  2000-10       Impact factor: 3.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.